QA: Elicio Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001601485_2025_Elicio_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001601485, Elicio Therapeutics Inc

  xvar xval
0 AssetsCurrent 20,693,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 483,000
3 remainder_Assets 7,002,000
4 LiabilitiesCurrent 11,523,000
5 LiabilitiesNoncurrent 5,105,000
6 remainder_Liabilities 22,862,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,409,028
9 ResearchAndDevelopmentExpense 30,384,520
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -4,330,623
13 remainder_ComprehensiveNetIncome -39,249
  yvar yval
0 Assets 28,178,000
1 Liabilities 39,490,000
2 Expenses 41,793,548
3 Revenues 0
4 StockholdersEquity -11,312,000
5 NetIncome -46,124,171
6 ComprehensiveNetIncome -46,143,796
7 BaseVar 56,915,710
8 EconomicCapitalRatiobeforeLimitedLiability -2.09
9 EconomicCapitalRatio 0.994

Edgar->Model Mapping

Feature Distribution

Change over Time